Clinical Data

TIKOSYN® (dofetilide) helped convert patients to normal sinus rhythm (NSR)1,2

  • TIKOSYN 500 mcg BID was shown to convert patients with atrial fibrillation or atrial flutter (AF/AFL) of more than 1 week duration to NSR at rates of 30% and 29% in 2 large pivotal studies2*

TIKOSYN helped maintain efficacy among patients converted to NSR2,3 

  • In 2 large registration trials, 87% of patients receiving TIKOSYN 500 mcg BID who were in NSR at 6 months were still in NSR at 12 months2*

Back to Top